Endocrine gland cancer
- PMID: 8001005
- DOI: 10.1002/1097-0142(19950101)75:1+<338::aid-cncr2820751316>3.0.co;2-f
Endocrine gland cancer
Abstract
Background: Incidence and prognosis of cancers of the endocrine glands vary greatly by histologic type.
Methods: Population-based data from SEER registries, 1973-1987, were analyzed.
Results: Thyroid cancer accounts for most (92%) of the cancers of the endocrine glands. The four major histologic types of thyroid cancer display distinct patterns, reflecting different biologic entities. Papillary carcinoma, the most common type, occurs more frequently in women than in men and in whites than in blacks and has an early onset. Follicular carcinoma, the second most common type, shows a steady increase in incidence with age and a female preponderance but no racial disparity. Medullary carcinoma, the rare differentiated thyroid tumor, has a female excess in whites only and a slow increase in incidence with age. Anaplastic carcinoma shows few racial or sex variations and reaches a substantial level only after age 50. The prognosis also varies greatly by histologic type. The overall 5-year relative survival rate is greater than 90% for papillary and follicular carcinomas, 82% for medullary carcinoma, and less than 10% for anaplastic carcinoma. Carcinomas of the suprarenal gland and thymus are rare, accounting for about 3% of endocrine cancers each. These tumors, unlike the differentiated thyroid cancer, show no female preponderance, have a higher incidence rate in blacks, and have a poorer survival rate.
Conclusions: The marked predominance of papillary carcinoma and the continued increase in its relative frequency characterize the postgoiter era and an increased use of scintigraphy and fine needle aspiration. Underdiagnosis of small tumors may explain the observed lower incidence of papillary carcinoma in blacks.
Similar articles
-
Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006.Thyroid. 2011 Feb;21(2):125-34. doi: 10.1089/thy.2010.0021. Epub 2010 Dec 27. Thyroid. 2011. PMID: 21186939 Free PMC article.
-
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Epidemiol Prev. 2016. PMID: 26951748
-
Endocrine cancer in Iran: based on cancer registry system.Indian J Cancer. 2006 Apr-Jun;43(2):80-5. doi: 10.4103/0019-509x.25889. Indian J Cancer. 2006. PMID: 16790945
-
Thyroid Cancer: 20-Year Comparative Mortality and Survival Analysis of Six Thyroid Cancer Histologic Subtypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration (SEER*Stat 8.3.2) A Systematic Review of 145,457 Cases for Diagnosis Years 1993-2013.J Insur Med. 2018 Jan;47(3):143-158. doi: 10.17849/insm-47-03-143-158.1. J Insur Med. 2018. PMID: 30192723
-
Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype--papillary, follicular, and anaplastic: a morphological and epidemiological study.Endocr Pathol. 2007 Spring;18(1):1-7. doi: 10.1007/s12022-007-0002-z. Endocr Pathol. 2007. PMID: 17652794 Review.
Cited by
-
Assessment of clinical and pathological features of patients who underwent thyroid surgery: A retrospective clinical study.World J Clin Cases. 2018 Mar 16;6(3):20-26. doi: 10.12998/wjcc.v6.i3.20. World J Clin Cases. 2018. PMID: 29564354 Free PMC article.
-
'I know I'm not invincible': An interpretative phenomenological analysis of thyroid cancer in young people.Br J Health Psychol. 2018 May;23(2):352-370. doi: 10.1111/bjhp.12292. Epub 2018 Jan 22. Br J Health Psychol. 2018. PMID: 29356226 Free PMC article.
-
Circ_0004851 regulates the molecular mechanism of miR-296-3p/FGF11 in the influence of high iodine on PTC.J Transl Med. 2024 Jun 20;22(1):586. doi: 10.1186/s12967-024-05405-2. J Transl Med. 2024. PMID: 38902782 Free PMC article.
-
Follicular adenoma and carcinoma of the thyroid gland.Oncologist. 2011;16(5):585-93. doi: 10.1634/theoncologist.2010-0405. Epub 2011 Apr 11. Oncologist. 2011. PMID: 21482585 Free PMC article.
-
The Role of M6A LncRNA Modification in Papillary Thyroid Cancer.Int J Mol Sci. 2025 Mar 21;26(7):2833. doi: 10.3390/ijms26072833. Int J Mol Sci. 2025. PMID: 40243425 Free PMC article. Review.